A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems

Clinical trial NCT05915702 · COMPLETED

Trial details

NCT number: NCT05915702
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Contrast Enhancement in Magnetic Resonance Imaging Central Nervous System Pathology

Start date: 2023-07-24
Primary completion: 2024-05-30
Enrollment: 303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.